Cellens was founded by Phuong (Jean) Pham in 2020.

How much funding has Cellens raised?

Cellens has disclosed $7M raised across 2 rounds.

Where is Cellens headquartered?

Cellens is headquartered in Boston, US.

Cellens

Boston, US · Founded 2020 · Delaware corporation

Cellens develops a non-invasive, urine-based cancer diagnostics platform (Octosense) that uses nanoscale atomic-force imaging of single-cell biophysical markers combined with machine learning to detect cancer, with early data focused on bladder cancer detection. It applies mechanobiology and label-free cell analysis to cancer screening.

AI & Machine LearningBiotechHealthtechMedical Devices

Founders & leadership

Cellens was founded in 2020 by Phuong (Jean) Pham.

Phuong (Jean) PhamCEO

Phuong Nhu PhamNamed on SEC filing

Board

Deborah ZajacBoard director

Lena Chaihorsky-HeringBoard director

Mohan IyerBoard director

Jesse SalkBoard director

Reported raises · per SEC filings

Form D private placements

$7M disclosed across 2 rounds · 2022–2025

▶$6.4MraisedNov 2025 · 33 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Deborah ZajacDirector
Lena Chaihorsky-HeringDirector
Mohan IyerDirector
Jesse SalkDirector
Phuong (Jean) PhamExecutive Officer, Director

Offering amount: $6.4M
Amount sold: $6.4M
Minimum investment: $747
First sale: Aug 2025
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$585KraisedOct 2022 · 15 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Phuong Nhu PhamExecutive Officer, Director

Offering amount: $1.5M
Amount sold: $585K
First sale: Apr 2022
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Linxens3 shared keywordsLinxens manufactures RFID inlays and microconnectors, contributing its industrial production expertise to projects such as Wibatts, which develops RFID tags that degrade and become unreadable when cold chain temperature limits are breached. Its technology targets the food and pharmaceutical industries where maintaining the cold chain across logistics, transport, and storage is critical.

Companies competing with Cellens for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Cellens do?: Cellens develops a non-invasive, urine-based cancer diagnostics platform (Octosense) that uses nanoscale atomic-force imaging of single-cell biophysical markers combined with machine learning to detect cancer, with early data focused on bladder cancer detection. It applies mechanobiology and label-free cell analysis to cancer screening.
Who founded Cellens?: Cellens was founded by Phuong (Jean) Pham in 2020.
How much funding has Cellens raised?: Cellens has disclosed $7M raised across 2 rounds.
Where is Cellens headquartered?: Cellens is headquartered in Boston, US.